L. Joseph Su, Ph.D., M.P.H.
Program Director, Modifiable Risk Factors Branch
National Institutes of Health
National Cancer Institute
Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
9609 Medical Center Drive, Rm. 4E212, MSC 9763
Bethesda, MD 20892
(For express delivery, use Rockville, MD 20850)
telephone: (240) 276-6822
Dietary intake assessment, biomarkers associated with cancer etiology and prognosis, carcinogenic chemicals in foods, and molecular mechanisms that underlie cancer risk, such as epigenetic changes. Cancer sites of special interest: prostate, ovary, pancreas, colon, and lung.
Ph.D. - Nutritional Epidemiology
University of North Carolina at Chapel Hill School of Public Health
M.P.H. - Public Health Nutrition
University of Minnesota
Dr. Su is a Nutritional Epidemiologist and Program Director in the Epidemiology and Genomics Research Program's (EGRP) Modifiable Risk Factors Branch (MRFB). His responsibilities include managing a research portfolio that focuses on cancer risk factors that may be modifiable, such as diet and nutrition, alcohol, physical activity, and energy balance.
He joined EGRP in 2009 from the Louisiana State University's (LSU) School of Public Health in New Orleans, where he was an Associate Professor of Epidemiology and Curriculum Coordinator for the Epidemiology Program. He also held a joint appointment in the LSU Department of Pathology where he had a laboratory for nutrient biomarker analysis.
Dr. Su has been the Principal Investigator or Co-Investigator of a variety of grants and contracts from NIH and other federal agencies, the State of Louisiana, and other funding sources. Before joining LSU, Dr. Su was a Graduate Research Assistant at the University of North Carolina (UNC) at Chapel Hill School of Public Health, and later was an Adjunct Associate Professor with that School and the School of Journalism and Mass Communication.
He also has experience as a reviewer for NIH's Center for Scientific Review's (CSR) Epidemiology and Cancer (EPIC) Study Section and the NCI Special Emphasis Panel.